Your browser doesn't support javascript.
loading
Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors.
AlDubayan, Saud H; Pyle, Louise C; Gamulin, Marija; Kulis, Tomislav; Moore, Nathanael D; Taylor-Weiner, Amaro; Hamid, Anis A; Reardon, Brendan; Wubbenhorst, Bradley; Godse, Rama; Vaughn, David J; Jacobs, Linda A; Meien, Stefanie; Grgic, Mislav; Kastelan, Zeljko; Markt, Sarah C; Damrauer, Scott M; Rader, Daniel J; Kember, Rachel L; Loud, Jennifer T; Kanetsky, Peter A; Greene, Mark H; Sweeney, Christopher J; Kubisch, Christian; Nathanson, Katherine L; Van Allen, Eliezer M; Stewart, Douglas R; Lessel, Davor.
Afiliação
  • AlDubayan SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Pyle LC; Cancer Program, the Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Gamulin M; Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts.
  • Kulis T; Department of Medicine, King Saud bin Abdul-Aziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Moore ND; Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Taylor-Weiner A; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Hamid AA; Division of Medical Oncology, Urogenital Unit, Department of Oncology, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Reardon B; Department of Urology, University Hospital Center Zagreb, University of Zagreb, School of Medicine, Zagreb, Croatia.
  • Wubbenhorst B; Cancer Program, the Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Godse R; Cancer Program, the Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Vaughn DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Jacobs LA; Cancer Program, the Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Meien S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Grgic M; Cancer Program, the Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Kastelan Z; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Markt SC; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Damrauer SM; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Rader DJ; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Kember RL; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Loud JT; Division of Medical Oncology, Urogenital Unit, Department of Oncology, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Kanetsky PA; Department of Urology, University Hospital Center Zagreb, University of Zagreb, School of Medicine, Zagreb, Croatia.
  • Greene MH; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Sweeney CJ; Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Kubisch C; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Nathanson KL; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Van Allen EM; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
  • Stewart DR; Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Lessel D; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
JAMA Oncol ; 5(4): 514-522, 2019 Apr 01.
Article em En | MEDLINE | ID: mdl-30676620
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Testiculares / Neoplasias Embrionárias de Células Germinativas / Predisposição Genética para Doença / Quinase do Ponto de Checagem 2 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male Idioma: En Revista: JAMA Oncol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Testiculares / Neoplasias Embrionárias de Células Germinativas / Predisposição Genética para Doença / Quinase do Ponto de Checagem 2 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male Idioma: En Revista: JAMA Oncol Ano de publicação: 2019 Tipo de documento: Article